Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Axovant Sciences Ltd.

Division of Roivant Sciences GMBH
www.axovant.com

Latest From Axovant Sciences Ltd.

Procurement In Practice: For Roivant Sciences, Speed Is The VANTage Point

Roivant has a unique business model of a connected family of operationally independent companies – known as “Vants” – each with a mission to develop and commercialize new therapies for patients with unmet medical needs. In an interview with Roivant's Kris Ungvarsky, In Vivo takes a closer look at how this affect sourcing and procurement.

Business Strategies Growth

After Bad Data Comes Layoffs – Will The Next Job Cuts Be At Anthera?

Anthera is exploring strategic alternatives after its lead drug candidate Sollpura failed in Phase III, which means layoffs may be coming soon. Several other biopharma companies have had to turn to job cuts already this year.

Business Strategies Clinical Trials

Deal Watch: Roivant Adds Ligand's Glucose Receptor Antagonist To Metavant Pipeline

Celgene will pursue "high-impact" indications using Vividion's proteomics technology, while Magenta will use Heidelberg's technology to try to optimize bone marrow transplants.

Deals M & A

Appointments: Changes At Axovant Sciences, Immunocore, Sangamo Therapeutics, Circassia, MaxCyte and CANbridge Life Sciences

Pharma and biotech appointments this week include a management shake up at Axovant Sciences, a new CEO at Immunocore, Sangamo's latest legal hire, and new board members at Circassia and MaxCyte.
Appointments BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Roivant Neurosciences Ltd.
  • Ownership
  • Public
  • Headquarters
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Roivant Sciences GMBH
  • Senior Management
  • Paul Cheruvu, MD, CEO
    Gregory Weinhoff, CFO
    Lawrence T Friedhoff, MD, Chief Dev. Officer
    Mark Altmeyer, Pres. & Chief Commercial Officer
  • Contact Info
  • Axovant Sciences Ltd.
    Phone: 441 824 8100
    2 Church St., Clarendon House
    Hamilton, Bermuda, HM 11
Advertisement
Advertisement
UsernamePublicRestriction

Register